Life Sciences & Health

Life Sciences & Health

Our dynamic and progressive Life Sciences team is nimble, creative and innovative in their approach to pushing the boundaries of science and law and bringing you closer to your aspirations and goals.

Patent Litigation Firm of the Year: Pharmaceuticals

LMG Life Sciences Awards EMEA 2023

2 x Impact Cases of the Year

LMG Life Sciences Awards EMEA 2023

Tier 1 Life Sciences and Healthcare

Legal 500 2024

Our team offers clients a full-service approach, with transactional, tax, competition, intellectual property, medicines regulatory and compliance professionals working seamlessly together to support Life Sciences companies who push the boundaries of science and law.

 

Please select

Out-Law / Your daily need to know

Our latest work

Our advisers act on domestic and international projects of all shapes and sizes, working with many of the leading names across this diverse sector. Browse our experience below, or use the filters to look-up recent work in particular geographies and legal disciplines.

    Our expertise, at your disposal

    With over 430 partners and 3000 people around the world, we are well-placed to support you across a full range of legal and advisory services.

    Latest press releases

    Show me all press releases

    Pinsent Masons advises Skillko on sale to HSI

    Multinational law firm Pinsent Masons through its Dublin office Pinsent Masons Ireland LLP has advised the founders of Skillko, Dermot O’Connor and Brendan Moloney, on its sale to US buyer HSI.

    Pinsent Masons advises syndicate of Taiwanese banks on funding of New South Wales warehouse project

    Multinational law firm Pinsent Masons has advised KGI Bank Co., Ltd, Taishin International Bank Co., Ltd and O-Bank Limited on the above A$100 million funding of the construction of a warehouse and distribution facility in Sydney’s western suburbs.

    Pinsent Masons advises Techem on the sale of its company for €6.7bn

    Pinsent Masons has advised Techem Group on its acquisition from investors TPG and GIC for a total consideration of €6.7bn.

    We are processing your request. \n Thank you for your patience. An error occurred. This could be due to inactivity on the page - please try again.